Neuroprotective effect of 5-HT 1A receptor agonist, Bayx3702, demonstrated in vitro and in vivo

Author： Semkova I.   Wolz P.   Krieglstein J.  

Publisher： Elsevier

ISSN： 0014-2999

Source： European Journal of Pharmacology, Vol.359, Iss.2, 1998-10, pp. : 251-260

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The 5-HT 1A receptor agonist Bayx3702 inhibits apoptosis induced by serum deprivation in cultured neurons

By Ahlemeyer B.   Glaser A.   Schaper C.   Semkova I.   Krieglstein J.  

European Journal of Pharmacology, Vol. 370, Iss. 2, 1999-04 ,pp. : 211-216

Elsevier

Access to resources Recommend Favorite

The 5-HT 1A receptor agonist BAY x 3702 prevents staurosporine-induced apoptosis

By Suchanek B.   Struppeck H.   Fahrig T.  

European Journal of Pharmacology, Vol. 355, Iss. 1, 1998-08 ,pp. : 95-101

Elsevier

Access to resources Recommend Favorite

Discriminative stimulus properties of the 5-HT 1A receptor agonist BAY x 3702 in the rat

By De Vry J.   Jentzsch K.R.  

European Journal of Pharmacology, Vol. 357, Iss. 1, 1998-09 ,pp. : 1-8

Elsevier

Access to resources Recommend Favorite

Effect of sustained administration of the 5-HT 1A receptor agonist flesinoxan on rat 5-HT neurotransmission

By Haddjeri N.   Ortemann C.   de Montigny C.   Blier P.  

European Neuropsychopharmacology, Vol. 9, Iss. 5, 1999-09 ,pp. : 427-440

Elsevier

Access to resources Recommend Favorite

The in vivo pharmacological profile of eletriptan (UK-116,044): a potent and novel 5-HT 1B/1D receptor agonist

By Gupta P.   Butler P.   Shepperson N.B.   McHarg A.  

European Journal of Pharmacology, Vol. 398, Iss. 1, 2000-06 ,pp. : 73-81

Elsevier

Access to resources Recommend Favorite